| Symbol | TSX : AMB |
|---|---|
| Last trade | 0.07 |
| Volume | 20,620 |
| As of | 2008-11-20 13:07 EST |
| Note: Quotes are delayed. For informational purposes only. |
|
Investor contact
For any inquiries or to request literature, please contact :
Philippe Calais, Ph.D., Pharm.
President & CEO
Ambrilia Biopharma Inc.
1000 chemin du Golf
Verdun, Quebec H3E 1H4
Tel.: (514) 751-2003 ext. 235
E-mail: pcalais@ambrilia.com or ir@ambrilia.com
Only public information or information which could otherwise be disclosed in accordance with Ambrilia’s Corporate Communication and Disclosure Policy shall be utilized in responding to electronic inquiries. Therefore, please provide your telephone number so that we may reach you.